Old Web
English
Sign In
Acemap
>
authorDetail
>
Clifford Motley
Clifford Motley
Janssen Pharmaceutica
Pathology
Medicine
Phases of clinical research
Trabectedin
Oncology
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Exploration of tumor genetic alterations and associations with clinical outcomes: Retrospective genomic analysis of archived liposarcoma (LPS) and leiomyosarcoma (LMS) samples from phase III trial of trabectedin (T) versus dacarbazine (D).
2019
Journal of Clinical Oncology
Shibu Thomas
Shilpy Joshi
Dong Shen
Roland Elmar Knoblauch
Michael Gormley
George Wang
Deborah Ricci
Clifford Motley
Robert G. Maki
Margaret von Mehren
Shreyaskumar Patel
George D. Demetri
Show All
Source
Cite
Save
Citations (0)
Analysis of FGFR alterations from circulating tumor DNA (ctDNA) and Tissue in a phase II trial of erdafitinib in urothelial carcinoma (UC).
2019
Journal of Clinical Oncology
Ademi E. Santiago-Walker
Christopher Moy
Yauheniya Cherkas
Yohann Loriot
Arlene Odelia Siefker-Radtke
Clifford Motley
Anjali Narayan Avadhani
Anne OHagan
Peter De Porre
Matthew V. Lorenzi
Ian McCaffery
Show All
Source
Cite
Save
Citations (3)
Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D).
2018
Journal of Clinical Oncology
Gurpreet Kapoor
Weimin Li
Dong Shen
Roland Elmar Knoblauch
Michael Gormley
G. Wang
Deborah Ricci
Michael P. Smith
Clifford Motley
Sigrid Malbrain
Robert G. Maki
Margaret vonMehren
Shreyaskumar Patel
George D. Demetri
Show All
Source
Cite
Save
Citations (0)
1
map